Microbial Butyrate Deficiency Drives Brain CDKN2A Epigenetic Derepression via HDAC Loss in the Gut-Brain Axis

The field treats CDKN2A/B epigenetic activation as a cell-autonomous aging clock. But the gut-brain axis shows parallel p16INK4a rises in enteric neurons and forebrain progenitors, with blood CDKN2A correlating with brain changes. This systemic synchrony suggests an external signal.

The hypothesis: Age-related gut dysbiosis depletes microbial butyrate production, reducing systemic butyrate levels. Butyrate is a potent histone deacetylase (HDAC) inhibitor. Its decline removes HDAC inhibition specifically at the CDKN2A/B locus in brain progenitor and neuron populations, allowing local H3K4me3 accumulation and promoter hypermethylation paradoxically linked to activation. This creates a permissive chromatin state that primes the locus for Ets-1-driven transcription by inflammatory signals like IL-6, which themselves are amplified by gut barrier dysfunction caused by enteric p16INK4a accumulation.

Mechanistic rationale:

1. The Butyrate-Chromatin Link: Butyrate, especially from Faecalibacterium and Roseburia, inhibits HDACs, promoting histone acetylation at many loci. We hypothesize it has a selective repressive effect on CDKN2A/B. Its age-related decline would thus cause locus-specific de-repression. This explains the paradox: the correlation between hypermethylation and expression may reflect a shift to a "poised" or "transcription-ready" state enabled by histone modification changes, with DNA methylation alterations being a secondary, reinforcing mark.
2. Spatial Specificity: The brain and enteric nervous system are uniquely dependent on systemic butyrate (crossing the blood-brain and enteric barriers). Other tissues, like kidney, show tissue-specific caloric restriction effects, aligning with variable reliance on this microbial metabolite.
3. Bidirectional Amplification Loop: Enteric neuron senescence from this same process compromises gut tight junctions, increasing systemic endotoxin (LPS) and IL-6. IL-6 potentiates Ets-1 activity, which then further drives CDKN2A transcription in primed brain cells, completing a vicious cycle initiated by microbial aging.

Testable predictions:

1. Germ-free or antibiotic-treated aged mice will show reduced brain (hippocampal, subventricular zone) and enteric nervous system CDKN2A expression compared to conventionally aged mice, which will be restored by butyrate supplementation but not by non-HDAC inhibitory short-chain fatty acids like propionate.
2. In human cohort studies, low circulating butyrate levels (or low fecal butyrate producer abundance) will correlate more strongly with blood CDKN2A methylation/expression and cognitive metrics than with peripheral senescence markers like p21.
3. Direct chromatin immunoprecipitation (ChIP-seq) on hippocampal tissue from young vs. old, butyrate-supplemented vs. control mice will show a specific reduction in H3K4me3 and HDAC occupancy at the CDKN2A locus in the supplemented group, without a global decrease in activating marks.

This model positions the aging microbiome as a master regulator of a key senescence locus, transforming a correlational gut-brain axis into a tractable, epigenetically defined signaling pathway.